Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13D/A for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS).
- Disclosed ownership: 0%.
- Date of event: 26 Jan 2026.
PERCEPTIVE ADVISORS LLC - 26 Jan 2026 SCHEDULE 13D/A Report for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- ATXS
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13D/A
- Filing time
- 09 Feb 2026, 17:03:25 UTC
- Date of event
- 26 Jan 2026
- Previous filing
- 16 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 0% ownership in Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS) on 26 Jan 2026."
What Changed
- Previous schedule filing date: 16 Oct 2025.
- Current filing was accepted on 09 Feb 2026, 17:03.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 0% | 0 | 0 | 0 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | 0001224962 |
| Joseph Edelman | 0% | 0 | 0 | 0 | /s/ Joseph Edelman | Joseph Edelman | 0001164426 |
| Perceptive Life Sciences Master Fund, Ltd. | 0% | 0 | 0 | 0 | /s/ Joseph Edelman | By: Perceptive Advisors LLC, By: Joseph Edelman, Managing Member | 0001249675 |
| Perceptive Xontogeny Venture Fund, L.P. | 0% | 0 | 0 | 0 | /s/ Joseph Edelman | By: Perceptive Xontogeny Ventures GP, LLC; By: Joseph Edelman, Managing Member | 0001757940 |